University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also ...
Patients receiving an immune checkpoint inhibitor for a neoplasm face an increased risk for rheumatoid arthritis, an observational study found.
Diagnosed with stage 3B lung cancer in 2018, I joined a support group where I met Jim and Melanie, and learned about Jim's ...
Immune checkpoint inhibitors (ICIs), a major type of cancer immunotherapy, don't do much for hospitalized cancer patients, ...
Opinion
19 小时on MSNOpinion
"Without careful consideration of the impact of these changes, we risk long-term damage" to medical research, writes Dr. .
The BC Cancer Foundation is looking to raise $6.8 million to expand its provincial immunotherapy research program, a ...
Immune checkpoint inhibitors (ICIs), a major type of cancer immunotherapy, don't do much for hospitalized cancer patients, researchers at the Icahn ...
During a Case-Based Roundtable® event, Neeraj Agarwal, MD, and participants discussed how they might determine which ...
"TGFB2 has emerged as a master regulator of immune suppression, not just in cancer but across multiple chronic diseases,” said Dr. Trieu. "Our work on OT-101 aims to neutralize TGFB2-driven resistance ...
Disease control rate (DCR) of 78% (7 of 9) in combination escalation arm of MDNA11 with Merck’s (known as MSD outside of Canada and the US) KEYTRUDA® (pembrolizumab) in ongoing Phase 1/2 ABILITY-1 ...
Rice University computer scientist Lydia Kavraki has been elected to the National Academy of Engineering (NAE), one of the ...
A fundraiser to send a 23-year-old mum-of-one battling a terminal brain tumour to Germany for a revolutionary treatment has ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果